A preliminary study of left frontal region error negativity and symptom improvement in geriatric depression.
OBJECTIVE
This study tested the hypothesis that frontal error negative wave amplitude on EEG during Stroop test activation predict change in depressive symptoms in depressed elders.


METHODS
Twenty-two older patients with major depression received controlled treatment with citalopram at a target dose of 40 mg/day for 6 weeks. Paramedian error negative waves were recorded during Stroop activation before treatment.


RESULTS
Nine subjects who remained symptomatic had larger left frontal error negative waves than the subjects who achieved remission. Left frontal error negative waves were correlated with percent change of depressive symptoms from baseline. Other paramedian error negative waves did not distinguish remitted from unremitted subjects. Left frontal error negative waves were negatively correlated with Mattis Dementia Rating Scale scores for initiation/perseveration; these scores were lower in unremitted than remitted patients.


CONCLUSIONS
Increased left frontal error negative waves are associated with limited or slow change in depressive symptoms in elders receiving citalopram.
Weill Medical College, Cornell University, 21 Bloomingdale Road, White Plains, NY 10605, USA. bkalayam@med.cornell.edu
Balu
B
Kalayam
George S
GS
Alexopoulos
D000368:Aged; D001288:Attention / Q000502:physiology; D015283:Citalopram / Q000494:pharmacology / Q000627:therapeutic use*; D003220:Conflict, Psychological; D003866:Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D004569:Electroencephalography / Q000706:statistics & numerical data*; D005625:Frontal Lobe / Q000187:drug effects / Q000503:physiopathology*; D007839:Functional Laterality / Q000502:physiology*; D015577:Geriatric Assessment; D006179:Gyrus Cinguli / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors